Share this article and save a life!
Medicare just did something it has never done before. 🚨
I keep thinking about what this actually means.
Starting July 1, 2026, CMS is launching the Medicare GLP-1 Bridge Program. For the first time in the history of Medicare Part D, seniors can access GLP-1 medications for weight management, not just for Type 2 diabetes or sleep apnea.
Since Part D was created, federal law explicitly excluded drugs used solely for weight loss. That was not an oversight. It was a deliberate policy choice. That choice held for over two decades.
This week, it changed.
Here is what the AMA’s National Advocacy Update published on June 26 says you need to know.
Eligibility is clinical and specific. A beneficiary qualifies if they have a BMI of 35 or greater, or a BMI of 30 or greater with heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or higher, or a BMI of 27 or greater with prediabetes, a prior heart attack, prior stroke, or symptomatic peripheral artery disease.
The prior authorization process is entirely retrospective. Physicians prescribe first. The documentation, diagnosis, clinical indication, BMI, and comorbidities, gets submitted after the fact. That is not a clean workflow. It is one that will create confusion and denials if clinicians are not prepared today.
Here is what most people are missing. This bridge program is temporary. It is a demonstration program. It is not permanent coverage. CMS is essentially running a large-scale pilot to justify what the data has been telling us for years, that obesity is a disease and treating it saves the system money downstream.
But the implications are enormous right now. 🔍
Millions of Medicare beneficiaries with obesity-related comorbidities have been paying out of pocket or going without. Ozempic, Wegovy, and similar drugs cost over $1,000 per month without coverage. For seniors on fixed incomes, that is not a real option.
This bridge changes that calculus, at least temporarily.
For health systems, for primary care practices, for community health programs serving underserved older adults, this is the moment to get your clinical workflows ready. Retrospective prior auth is not forgiving. If your documentation protocols are not tight, your patients will get denied even when they are eligible.
At Oatmeal Health, we work on the front lines of preventive care access for underserved communities. I have watched too many patients fall through the gap between clinical need and coverage reality. This week felt different.
The coverage wall just cracked. The question is whether health systems move fast enough to actually get eligible patients through it.
**Medicare covering GLP-1s for weight management is not just a policy update. It is a generational shift in how America treats obesity.**
To every primary care physician, health system administrator, and Medicaid and Medicare policy lead reading this: Is your documentation workflow ready for July 1? Because the program starts whether your team is ready or not.
👉 Follow for daily healthcare insights. Deeper dives in The Oatmeal Bite on Substack.
Share this article and save a life!
Author:

Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.




